Narrative review discusses natural products and Chinese herbs for hepatorenal protection
This source is a narrative review rather than a systematic review or primary trial. The scope focuses on natural products such as herbal components, single Chinese medicinal herbs, and Chinese medicinal prescriptions. The review does not report a specific population, sample size, setting, or follow-up duration. Primary outcomes and secondary outcomes were not reported in the provided data.
The authors synthesize information to provide targeted theoretical support for the development of hepatorenal protective drugs. No pooled effect sizes or specific numerical data are available because the study type is a narrative review. The review does not report specific adverse events, serious adverse events, discontinuations, or tolerability profiles.
Limitations of this source include the lack of reported funding or conflicts of interest. The certainty of the findings is not explicitly stated, and the authors do not report specific limitations beyond the inherent nature of a narrative review. Practice relevance is limited to theoretical support rather than direct clinical guidance based on quantitative evidence.